U.S. Personal Products Stock News

CVR Energy overview and recent share performance CVR Energy (CVI) has drawn fresh attention after a sharp recent move in its share price, with the stock closing at $33.82 and posting notable returns over the past month and past 3 months. See our latest analysis for CVR Energy. The recent 51.25% 1 month share price return, on top of a 34.26% year to date share price return and a 59.53% 1 year total shareholder return, points to building momentum as investors reassess CVR Energy's risk and...

In March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services that lets eligible, average-risk customers request the FDA-approved, at-home Cologuard colorectal cancer screening test through its pharmacies, aiming to close care gaps with pharmacist-led services integrated into store workflows. At the same time, Exact Sciences highlighted new data on its Oncodetect molecular residual disease test and Cancerguard multi-cancer early detection assay at the...

If you are wondering whether HealthEquity is attractively priced or if the opportunity has already passed, this article walks through the key numbers that matter for valuation. The stock last closed at US$81.02, with returns of 4.1% over 7 days and 5.1% over 30 days. Year to date the return stands at an 11.0% decline and the 1-year return is a 4.5% decline, compared with a 44.6% gain over 3 years and 15.7% over 5 years. Recent headlines around HealthEquity have focused on its position in...

AGNC Investment (AGNC) has put dividends back in the spotlight after its Board declared a US$0.12 common stock dividend for March 2026, alongside fresh quarterly dividends across multiple preferred series. See our latest analysis for AGNC Investment. Despite the fresh dividend announcements, AGNC’s share price has been under pressure in the short term, with a 1‑month share price return of a 13.79% decline and a year-to-date share price return of a 10.80% decline. Its 1‑year and 3‑year total...

Earlier in March 2026, options traders showed unusually strong interest in Mobileye Global (NASDAQ: MBLY) calls ahead of its upcoming earnings, while Mobileye and Elektrobit announced a collaboration to integrate EB corbos Linux for Safety Applications into the Mobileye Drive Level 4 autonomous driving platform. This combination of options positioning and a safety-focused software partnership highlights how capital markets and technology ecosystems are converging around Mobileye’s autonomous...

Investors may be wondering if Home Depot at around US$320 a share still stacks up as good value, or if most of the upside has already been priced in. The stock is down 5.4% over the past week, 16.4% over the last month, and 7.2% year to date, while the 1 year return sits at a 6.3% loss and the 3 and 5 year returns are 22.2% and 19.3% respectively. Taken together, this provides a mixed picture of recent sentiment versus longer term performance. Recent headlines have focused on broader...

In March 2026, Kohl's reported fourth-quarter revenue of US$5,173 million and net income of US$125 million, alongside full-year revenue of US$15,527 million and net income of US$272 million, while guiding full-year 2026 net and comparable sales to range from a 2% decline to flat. Under new CEO Michael Bender, Kohl's halted further store closures, with about 1,150 locations and over 90% of stores profitable, signaling a shift toward improving performance at existing stores rather than...

Taysha Gene Therapies (NasdaqGS:TSHA) received FDA Breakthrough Therapy designation for TSHA-102 in Rett syndrome. The company reported a 100% patient response rate in pivotal Phase I/II data for TSHA-102. Regulators aligned with Taysha on pivotal trial designs for its lead Rett syndrome program. Taysha added a key commercial hire as it prepares for potential TSHA-102 commercialization. Taysha Gene Therapies, trading at $4.4 per share, has been drawing attention as its 1 year return stands...

Earlier in March 2026, Hormel Foods used Pizza Expo to showcase new offerings like Hot Calabrian Chili Sausage while outlining five emerging pizza trends centered on specialized heat, premium proteins, global fusion flavors, and crust innovation. By leaning into highly specific flavors such as Calabrian chili and protein-heavy "Triple Pepperoni" pies, Hormel is positioning its HORMEL and FONTANINI brands to capture evolving restaurant menus and consumer demand for more adventurous, artisanal...

Sterling Infrastructure (STRL) has drawn investor attention after recent trading, with the stock closing at $401.61. The move comes against a backdrop of mixed short term returns and strong multi year total returns. See our latest analysis for Sterling Infrastructure. The recent 1 day share price decline of 6.99% to US$401.61 comes after a 90 day share price return of 30.15% and a very large 5 year total shareholder return. This suggests that momentum has cooled in the short term, while...

For investors considering whether Verisk Analytics at around US$201.75 represents fair value or a potential opportunity, this article focuses on what the current price might imply. The stock recently posted a 0.3% return over 7 days and 9.6% over 30 days, while the year-to-date return is an 8.7% decline and the 1-year return is a 28.7% decline. Recent headlines have highlighted Verisk Analytics as a data and analytics provider in the commercial services space, with attention on how its core...

Diamondback Energy (FANG) has completed a follow-on equity offering of 11,000,000 common shares, raising about US$1.903 billion at US$173 per share. This event directly affects ownership dilution and capital structure. See our latest analysis for Diamondback Energy. That equity raise comes after a strong share price run, with Diamondback’s 30 day share price return of 10.65% and 90 day return of 29.98%, while the 5 year total shareholder return of 213.89% points to sustained long term...

Ambarella (NasdaqGS:AMBA) used a recent industry conference to outline a faster push into Edge AI products. The company highlighted a major shift in its revenue mix, new sales efforts aimed at smaller customers, and progress on a semi custom chip. Management also disclosed work on an upcoming two nanometer chip, signaling a move to more advanced manufacturing nodes. Ambarella, trading at about $54.02, has seen a mixed share price record, with a 3.3% gain over the past week but a 28.1%...

Wondering if Arm Holdings at US$132.35 is priced for its reputation or offering genuine value? This article breaks down what that current tag might really mean for you. The stock has posted a 14.3% return over the last 7 days, with gains of 4.0% over 30 days, 15.4% year to date and 11.2% over the past year, which has put its recent moves firmly on many investors' radars. Recent coverage has focused on Arm as a key listed way to gain exposure to semiconductor design and licensing, with...

Event overview and recent stock move Bullish (BLSH), a global digital asset platform, has drawn fresh attention after a sharp daily decline of about 4%, alongside a roughly 19% gain over the past month and a 15% decline in the past 3 months. See our latest analysis for Bullish. With a 19.2% 1 month share price return but a 14.9% 3 month share price decline and a year to date share price return of 3.3% in the red, recent momentum looks more like a rebound than a firmly established trend. This...

Yiren Digital (YRD) is back in focus after Q4 2025 results showed revenue of CN¥957.63 million, a net loss of CN¥882.16 million, and a temporary suspension of its cash dividend for the second half of 2025. See our latest analysis for Yiren Digital. The earnings miss and dividend suspension appear to have weighed heavily on sentiment, with a 7 day share price return of 44.19% and a 1 year total shareholder return of 69.72%. The 3 year total shareholder return remains slightly positive, which...

RTX (RTX) has been in focus after reporting revenue growth of 12.1% year on year, beating analyst expectations by 7%, with management highlighting strong sales, adjusted EPS and free cash flow. See our latest analysis for RTX. The latest earnings beat and recent production expansions at Raytheon facilities sit against a share price of US$198.16 and mixed recent momentum, with a 90 day share price return of 8.87% but a 7 day decline of 3.11%. The 1 year total shareholder return of 52.23%...

Recent analyst commentary on Enovix (ENVX) is highlighting a mix of long term optimism around its high energy density lithium ion batteries, along with caution about manufacturing hurdles, negative margins, and cash burn tied to scaling production. See our latest analysis for Enovix. The share price has been under pressure, with a 1 month share price return showing an 18.32% decline and a year to date share price return showing a 38.40% decline. The 1 year total shareholder return of 42.49%...

Investor Day puts nVent Electric (NVT) data center and utility focus in the spotlight nVent Electric (NVT) has drawn fresh attention after its 2026 Investor Day in New York, where management outlined portfolio changes, a growth plan tied to AI driven data centers and power utilities, and new financial targets. See our latest analysis for nVent Electric. Despite a 5.1% decline in the 1 day share price after Investor Day, the stock still carries strong momentum, with a 90 day share price return...

Gartner stock performance snapshot With no single headline event driving attention today, Gartner (IT) is drawing interest as investors reassess its share performance, its business mix across research, conferences, and consulting, and its recent return profile over the past month and the past 3 months. See our latest analysis for Gartner. The recent 1 day share price return of 1.35% contrasts with a 90 day share price return of 35.63% decline and a 1 year total shareholder return of 62.5%...

In recent days, 10x Genomics has come under pressure as Cathie Wood’s ARK Invest sold more than 473,000 shares, prompting wider concerns among investors already uneasy about the company’s muted 2026 revenue growth guidance. At the same time, 10x Genomics’ technology featured in PerturbAI’s release of a massive in vivo CRISPR brain atlas, highlighting the company’s tools as core infrastructure for cutting-edge AI-driven genomics research. Next, we’ll examine how ARK Invest’s large share sale...

Assessing the recent move in Hawaiian Electric Industries Hawaiian Electric Industries (HE) has been drawing attention after a period of mixed share performance, with a month return of about a 12% decline contrasted with an approximately 23% gain over the past 3 months. See our latest analysis for Hawaiian Electric Industries. At a share price of $14.06, Hawaiian Electric Industries has recently given back some ground, with a 7 day share price return of about a 4% decline and a 30 day share...

WESCO International (WCC) just delivered Q4 2025 revenue of US$6.1b, up 10% year over year, and raised its 2025 guidance, with a rapidly growing data center business now nearing 20% of total revenue. See our latest analysis for WESCO International. Despite the strong Q4 update and raised 2025 guidance, WESCO International’s recent share price has cooled, with a 17.14% 1 month share price return decline, even as the 1 year total shareholder return stands at 55.01%. This suggests strong longer...

Shake Shack (SHAK) is expanding its Canadian footprint, with its first Western Canada location set to open this spring at Calgary’s CF Chinook Centre. This move highlights the chain’s ongoing international growth ambitions. See our latest analysis for Shake Shack. At a share price of $87.63, Shake Shack has seen a 4.98% year to date share price return, while the 1 year total shareholder return of 3.38% contrasts with a much stronger 3 year total shareholder return of 66.72%. This suggests...